Viewing Study NCT06662656


Ignite Creation Date: 2025-12-24 @ 11:32 PM
Ignite Modification Date: 2026-01-01 @ 9:14 PM
Study NCT ID: NCT06662656
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-10-29
First Post: 2024-03-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: ED50 of Sufentanil for Intraoperative Analgesia
Sponsor: China International Neuroscience Institution
Organization:

Study Overview

Official Title: ED50 of Sufentanil with Dexmedetomidine Analgesia During Laparoscopic Cholecystectomy
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: ED50
Brief Summary: 1. Sufentanil as an strong analgesic is used widespreadly during laparoscopic cholecystectomy.
2. Lower dosages of sufentanil facilitated with dexmedetomidine can offer enough analgesia effect.
3. The investigator are planning use the most classical method for determining the ED50 or half effective concentration of sufentanil facilitated with dexmedetomidine using sequential method, which is also called" up and down method" and" ladder method".
Detailed Description: The concordance of the current research is that lower dosages of sufentanil facilitated with dexmedetomidine can offer enough analgesia effect through operation. However, the dosages of sufentanil used in various researches vary greatly of operations. Previous studies have shown that the amount of sufentanil required for intraoperative analgesia is smaller than that required while dexmedetomindine facilitated. Although the appropriate dosage of sufentanil required for operation can ensure the analgesic effect of operation, excessive dosage can cause severe choking during intubation, postoperative nausea and vomiting, hyperalgesia, and chronic postoperative pain. The investigator planning use the most classical method for determining the ED50 or half effective concentration of sufentainl combined with dexmedetomidine using sequential method, which is also called " up and down method" and " ladder method".

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
CINI-AD-202403-13 OTHER XuanWu Hospital View